E-LIB Suche - Ergebnisse für: Suárez Tembra, M.

1

Efficacy and safety of replacing sitagliptin with canaglifl..:

Garcia de Lucas, M.D. ; Pérez Belmonte, L.M. ; Suárez Tembra, M...
Diabetes & Metabolism. 44 (2018) 4 - p. 373-375 , 2018

Link: https://doi.org/10.1016/..

2

Molecular basis of the familial chylomicronemia syndrome in..:

Ariza, María José ; Rioja, José ; Ibarretxe, Daiana...
Journal of Clinical Lipidology. 12 (2018) 6 - p. 1482-1492.e3 , 2018

Link: https://doi.org/10.1016/..

3

Prevalence of obesity according to Edmonton staging in the ..:

Carretero Gómez, J. ; Arévalo Lorido, J.C. ; Gómez Huelgas, R....
Revista Clínica Española (English Edition). 217 (2017) 2 - p. 71-78 , 2017

Link: https://doi.org/10.1016/..

4

Variation of the concentration of lipoprotein (a) according..:

Perez-calahorra, S. ; Mateo-Gallego, R. ; Plana, N....
Atherosclerosis. 275 (2018) - p. e163-e164 , 2018

Link: https://doi.org/10.1016/..

5

Cardiovascular disease in heterozygous familial hypercholes..:

Marco-Benedi, V. ; Perez-Calahorra, S. ; Plana, N....
Atherosclerosis. 252 (2016) - p. e44 , 2016

Link: https://doi.org/10.1016/..

6

Prevalence of metabolic syndrome and cardiovascular disease..:

Ascaso, Juan F. ; Millán, Jesús ; Mateo-Gallego, Rocio...
European Journal of Internal Medicine. 22 (2011) 2 - p. 177-181 , 2011

Link: https://doi.org/10.1016/..

7

Influence of triglyceride concentration in lipoprotein(a) a..:

Marco-Benedí, Victoria ; Cenarro, Ana ; Laclaustra, Martín...
Clínica e Investigación en Arteriosclerosis (English Edition). 36 (2024) 2 - p. 71-77 , 2024

Link: https://doi.org/10.1016/..

8

Effect of lipid-lowering treatment in cardiovascular diseas..:

Perez-Calahorra, S ; Laclaustra, M ; Marco-Benedí, V...
info:eu-repo/grantAgreement/EUR/ISCII-ERDF/A way to make Europe. , 2019

Link: http://zaguan.unizar.es/..

9

Effect of lipid-lowering treatment in cardiovascular diseas..:

Perez-Calahorra S ; Laclaustra M ; Marco-Benedí V...
http://hdl.handle.net/20.500.11797/imarina4225962. , 2019

Link: https://hdl.handle.net/2..

10

How many familial hypercholesterolemia patients are eligibl..:

Masana, L ; Plana, N ; Pérez-Calahorra, S...
info:eu-repo/grantAgreement/ES/FIS/PI15-01983. , 2017

Link: http://zaguan.unizar.es/..

11

How many familial hypercholesterolemia patients are eligibl..:

Masana L ; Plana N ; Pérez-Calahorra S...
http://hdl.handle.net/20.500.11797/imarina2850107. , 2017

Link: https://hdl.handle.net/2..

12

Prevalence of metabolic syndrome and cardiovascular disease..:

Ascaso, Juan F ; Millán, Jesús ; Mateo-Gallego, Rocío...
0953-6205. , 2011

Link: https://hdl.handle.net/2..

13

WITHDRAWN: Consensus on lipoprotein(a) of the Spanish Socie..:

Delgado-Lista, Javier ; Mostaza, Jose M. ; Arrobas-Velilla, Teresa...
Clínica e Investigación en Arteriosclerosis (English Edition). , 2024

Link: https://doi.org/10.1016/..

14

Consensus on lipoprotein(a) of the Spanish Society of Arter..:

Delgado-Lista, Javier ; Mostaza, Jose M. ; Arrobas-Velilla, Teresa...
Clínica e Investigación en Arteriosclerosis (English Edition). 36 (2024) 4 - p. 243-266 , 2024

Link: https://doi.org/10.1016/..

15

Consenso sobre lipoproteína (a) de la Sociedad Española de ..:

Delgado-Lista, Javier ; Mostaza, Jose M. ; Arrobas-Velilla, Teresa...
Clínica e Investigación en Arteriosclerosis. 36 (2024) 4 - p. 243-266 , 2024

Link: https://doi.org/10.1016/..